Niv Caviar, M.B.A
Chief Executive Officer
Mr. Caviar is a successful life science CEO, general manager with senior functional management experience in marketing, business development, strategic planning, engineering/manufacturing and finance (Nasdaq CFO). He successfully led, raised, and negotiated 35+ partner and financial transactions for $2.5 billion in total deal capital. Mr. Caviar was responsible for commercialization/marketing and product launch for five branded products (Rx small molecule, medical device, and biologic/injectables). He is an accomplished senior leader in pharmaceutical, biotech, and medical device industry segments, with management/leadership experience in both public and private (venture and private equity) companies. Niv Caviar is the former CEO of Suneva Medical, CFO/CBO of La Jolla Pharma (LJPC: Nasdaq), VP of Bus Development and VP, Head of Dermatolgoy Marketing at Allergan. Mr. Caviar holds an M.B.A from Harvard Business School.
Neville Alleyne, M.D.
Chief Medical Officer, Founder
Dr. Alleyne is a board-certified orthopedic surgeon and is the Director of the Orthopedic Spine Center at Tri-City Medical Center in Oceanside, CA. Dr. Alleyne’s practice is focused on treating a broad spectrum of spinal disorders, and he has established a multi-disciplinary approach, using the latest minimally invasive techniques, to relieve pain and restore spinal stability and mobility. He founded and served as chief medical director for several start-up companies developing spinal barriers and instrumentation using pedicle screws, cervical plates and artificial discs, including ProSpine, NAS Medical, and Smartdisc Inc. Dr. Alleyne is the inventor on numerous published patent applications related to spinal methods and devices. He is a member of the American Academy of Orthopedic Surgeons, the North American Spine Society, the California Orthopedic Association and the J. Robert Gladden Orthopaedic Society. Dr. Alleyne performed his fellowship training in total joint arthroplasty and spine surgery at Harvard University-Massachusetts General Hospital and New England Baptist Hospital in Boston, MA. Dr. Alleyne completed his residency training at Yale New Haven Hospital in orthopedics and general surgery in 1988. Dr. Alleyne received his medical degree from Mount Sinai School of Medicine in 1983 and was an undergraduate at Columbia University in New York, NY.
Nick J. Manesis, Ph.D.
Chief Technology Officer
Dr. Manesis has over 27 years of experience focused on R & D in the Life Sciences space. He has successfully driven both new product and existing product activities for high profile companies as Allergan, CooperVision, and Hewlett-Packard Company. He has provided leadership and management to large cross-functional teams across multiple projects both domestically and internationally. He is a strong advocate of customer-supplier principles, both internally and externally. Dr. Manesis holds a Ph.D. In Chemistry and has expertise in biomaterials within the medical device industry.
Scott Mortimer, MBA
Vice President, Corporate Development & Marketing
Mr. Mortimer has over 25 years of experience in the biopharma and medical technology industries. He is a principal of Mirsona Consulting, a life sciences practice focusing on marketing strategy and business development for biopharmaceutical and medical technology companies. Previously, Mr. Mortimer was Sr. Director of New Product Planning & Portfolio Management for Impax Labs, responsible for brand pipeline product strategy and commercial planning. Prior to that he worked as Director of Marketing at PDL BioPharma and led the specialty therapeutics commercial marketing group. Earlier in his career, he held commercial marketing roles at MedImmune and prior to that at Merck & Co. where worked in sales, market development and marketing. Mr. Mortimer received an MBA from UC Davis, Graduate School of Management and a BA from Georgetown University.
Jessie Elchico, B.S, M.T., ASCP
Vice President, Quality and Compliance
Ms. Elchico has over 30 years of Quality Operations experience in the biopharmaceutical and medical device industries supporting recombinant proteins, vaccines, small molecules, oligonucleotides and drug/device combination products. She has been consulting for biopharmaceutical companies in QA and compliance and most recently was VP of Quality Operations at The Medicines Company supporting IONSYS®, a drug/device combination product. Prior to this, she joined AstraZeneca in Santa Clara, CA as Quality Site Head. She joined Polypeptide Laboratories as VP of Quality, US Operations in 2009. She joined La Jolla Pharmaceutical Company in 2004 as VP of Quality Operations and Analytical Development. Ms. Elchico spent 11 years at Chiron Corporation, the last 7 years as VP of Quality Assurance, BioPharma Division. Ms. Elchico received her BS degree in Medical Technology from the University of San Agustin, Philippines and completed her medical technology training at St. Peter’s General Hospital, New Brunswick, NJ.
Catherine Thompson, Ph.D.
Vice President, Clinical Development
Gianfranco Bellezza, M.D.
Senior Director, Medical Affairs
Dr. Bellezza has founded and advised multiple medical device companies over his 35-year career in Europe. He also has significant experience in hospital, healthcare and related legislation in Europe and America and been strategic advisor in clinical development, regulatory validation, certification, and marketing of innovative and disruptive medical devices. Dr. Bellezza is specialized in multiple areas of healthcare and related therapies, including orthopedics, neurosurgery, pain therapy, oncological surgery, interventional radiology, otolaryngology, tissue technology, biomaterials and advanced cell therapies. He founded 6 companies, has been CEO of 5 medical companies and served as European Clinical Director in 8 European and American medical companies. He is winner of several awards in the medical field and contributed to the exit of 6 companies. Dr. Bellezza received his medical training at Università degli Studi di Milano and resides in Switzerland.